Induction of apoptotic pathway in the vestibule of cisplatin (CDDP)-treated guinea pigs

K Watanabe1, K Jinnouchi, S Baba

  • 1Department of Oto-rhino-laryngology, Nippon Medical School, Tokyo, Japan. bxp02646@nifty.ne.jp

Anticancer Research
|March 26, 2002
PubMed
Abstract

Insights

Cisplatin induces apoptosis in guinea pig vestibules, evidenced by caspase-activated deoxyribonuclease and caspase 3 in key areas. This suggests apoptosis contributes to vestibular dysfunction in cisplatin-treated patients.

Area of Science:

  • Ototolaryngology
  • Cell Biology
  • Toxicology

Background:

  • Apoptosis involves DNA fragmentation by caspases and caspase-activated deoxyribonuclease.
  • Cisplatin is a chemotherapy drug known to induce apoptosis.

Purpose of the Study:

  • To investigate the role of apoptosis in cisplatin-induced vestibular changes in guinea pigs.
  • To examine the expression of apoptosis markers in the guinea pig vestibule after cisplatin administration.

Main Methods:

  • Guinea pigs were injected with cisplatin (10 mg/kg).
  • Temporal bones were harvested 3 days post-injection.
  • Immunohistochemistry was performed to detect caspase-activated deoxyribonuclease and caspase 3.

Main Results:

  • Caspase-activated deoxyribonuclease and caspase 3 were detected in the dark cell area, transitional area, and sensory epithelium.
  • These findings indicate apoptotic activity in specific vestibular regions.

Conclusions:

  • Apoptosis is a significant mechanism underlying cisplatin-induced ototoxicity.
  • The observed apoptotic changes suggest a link between cisplatin treatment and vestibular dysfunction.